ABT and DXCM Related Headlines
Go Back- Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
- Bernstein Shares Takeaways From the 5th Annual Diabetes Disruptor Conference
- Piper Sandler on calls with diabetes clinicians
- Oppenheimer sees stronger growth at Boston Scientific
- Piper Sandler's Key MedTech Takeaways From ADA 2025
